Top Markets
#1 Akedo Akedo +62.21%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.61%
#4 Cross Cross +42.54%
#5 Black Phoenix Black Phoenix +34.09%
#6 Velvet Velvet +30.86%
#7 OVERTAKE OVERTAKE +24.86%
#8 Cap Cap +16.59%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.42%
#10 Bitway Bitway +12.57%
Coin of the day
Akedo Akedo
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Exopharm Limited Exopharm Limited

Exopharm Limited

EX1
Classifica tra le azioni #39130
Exopharm Limited is an Australian clinical-stage firm dedicated to developing... Exopharm Limited is an Australian clinical-stage firm dedicated to developing groundbreaking therapeutics utilizing extracellular vesicles (EVs). Its core technologies include an extracellular vesicle positioning system (EVPS), which facilitates the precise targeting of exosomes by attaching specific molecules to their surface, guiding them to particular tissues or cell types. Another innovation is oligonucleotide packing, designed to optimize therapeutic delivery by preferentially loading specific RNA molecules into exosomes as medicinal cargo. Additionally, Exopharm employs ligand-based exosome affinity purification for effectively isolating and refining exosomes from biological fluids such as blood and cell culture media. The company's engineered EV product portfolio features Fortrexo CoV, aimed at treating SARS-CoV-2 infections; Cognevo, developed for neurodegenerative diseases; and PlexoDox, intended for cancer treatment. Exopharm Limited also maintains a research collaboration with Showa Denko Materials Co., Ltd. The company was founded in 2013 and is headquartered in Melbourne, Australia.
Prezzo delle azioni
$0.00700343
Ultima sincronizzazione: 2023-10-30
Capitalizzazione di mercato
$637.31K
Variazione (1 giorno)
0.50%
Variazione (1 anno)
0.00%
Paese
AU
Scambia Exopharm Limited (EX1)

Categoria

Healthcare
Storico del prezzo dell'azione per Exopharm Limited (EX1)
Prezzo di chiusura più alto: $0.01 il 2023-10-01

Prezzo di chiusura più basso: $0.35 il 2018-12-01
Storico del prezzo dell'azione di Exopharm Limited dal 2018 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2023 -85.98%
2022 -83.97%
2021 9.37%
2020 40.18%
2019 -42.20%
2018 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $506.54 29.78%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $843.80 29.33%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $729.87 6.86%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $252.41 11.51%
BE